NEFAZ Publicly Traded Company (NFAZ.ME)
RUB 245.0
(0.0%)
RUB 245.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.19 Billion | -1.38 Billion | 153.27 Million | 659.07 Million | -204.6 Million | -16.68 Million |
| Net Income | 143.84 Million | 321.8 Million | 611.24 Million | 288 Million | -209.98 Million | 101 Thousand |
| Depreciation & Amortization | 175.03 Million | 216.26 Million | 132.35 Million | 136.48 Million | 139.93 Million | 145.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 3.87 Billion | -1.92 Billion | -590.31 Million | 234.58 Million | -134.56 Million | -101 Thousand |
| Investing Cash Flow | -297.57 Million | -37.94 Million | -57.82 Million | -22.51 Million | -39.19 Million | -16.68 Million |
| Investments in PPE | -302.72 Million | -48.86 Million | -63.73 Million | -35.29 Million | -47.05 Million | -20.11 Million |
| Acquisitions | - | - | - | 12.78 Million | 1.84 Million | 3.63 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 1.84 Million | - |
| Other Investing Activities | 5.15 Million | 10.92 Million | 5.91 Million | 12.78 Million | 6.01 Million | -16.68 Million |
| Financing Cash Flow | -3.75 Billion | 1.79 Billion | -335.77 Million | -415.09 Million | 231.21 Million | -9.2 Million |
| Debt repayment | -4.15 Billion | -2.91 Billion | -5.72 Billion | -4.97 Billion | -4.73 Billion | -3.43 Billion |
| Dividends payments | - | - | - | - | - | -14 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 392.98 Million | 4.71 Billion | 5.39 Billion | 4.55 Billion | 4.96 Billion | 3.42 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 371.23 Million | 23.18 Million | 262.5 Million | 45.67 Million | 59.07 Million | 146.43 Million |
| Cash at end of period | 497.5 Million | 371.23 Million | 23.18 Million | 262.5 Million | 45.67 Million | 59.07 Million |
| Capital Expenditure | -302.72 Million | -48.86 Million | -63.73 Million | -35.29 Million | -47.05 Million | -20.11 Million |
| Effect of forex changes on cash | -12.57 Million | -24.56 Million | 1 Million | -4.63 Million | -821 Thousand | -1.64 Million |
| Net cash flow / Change in cash | 126.26 Million | 348.04 Million | -239.31 Million | 216.83 Million | -13.4 Million | -87.36 Million |
| Free Cash Flow | 3.89 Billion | -1.43 Billion | 89.54 Million | 623.77 Million | -251.65 Million | -36.8 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 143.84 Million | -46.05 Million | 900.29 Million | 321.8 Million | -105.81 Million | -219.04 Million |
| Depreciation & Amortization | 175.03 Million | - | - | 216.26 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 3.87 Billion | 46.05 Million | -900.29 Million | -1.92 Billion | 105.81 Million | 219.04 Million |
| Investing Cash Flow | -297.57 Million | - | - | -37.94 Million | - | - |
| Investments in PPE | -302.72 Million | - | - | -48.86 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.15 Million | - | - | 10.92 Million | - | - |
| Financing Cash Flow | -3.75 Billion | - | - | 1.79 Billion | - | - |
| Debt repayment | -4.15 Billion | - | - | -2.91 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 392.98 Million | - | - | 4.71 Billion | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 371.23 Million | - | - | 23.18 Million | - | - |
| Cash at end of period | 497.5 Million | - | - | 371.23 Million | - | - |
| Capital Expenditure | -302.72 Million | - | - | -48.86 Million | - | - |
| Effect of forex changes on cash | -12.57 Million | - | - | -24.56 Million | - | - |
| Net cash flow / Change in cash | 126.26 Million | - | - | 348.04 Million | - | - |
| Free Cash Flow | 3.89 Billion | - | - | -1.43 Billion | - | - |
EXRO
002302
VSL
CSW-A
PRADPME
NGEN